Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe page history shows a new release identifier (v3.5.5) replacing the previous v3.5.4. This indicates a site-level update to the interface.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision label v3.5.4 appears, replacing the previous v3.5.3 in the record history. This indicates a published update to the page metadata without changing the underlying study details.SummaryDifference0.1%

- Check45 days agoChange DetectedUpdates the ClinicalTrials.gov page revision/version indicator from v3.5.2 to v3.5.3, with no change to the underlying study record content.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.5.0 was added and revision v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision changed from v3.4.2 to v3.4.3 in the Record History. No study content or user actions are affected.SummaryDifference0.1%

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.